Sam Eldessouky - 26 Feb 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Source evidence 5 source fields
Form type
4
Accepted by SEC
02 Mar 2022, 20:00:19 UTC
Previous filing
15 Jun 2021
Next filing
07 Mar 2022
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Christina Ackermann, attorney-in-fact

Key filing fact

Sam Eldessouky filed Form 4 for Bausch Health Companies Inc. (BHC) on 02 Mar 2022.

Key facts

  • This page summarizes Sam Eldessouky's Form 4 filing for Bausch Health Companies Inc. (BHC).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2022, 20:00.

Change

  • Previous filing in this sequence was filed on 15 Jun 2021.
  • Current net transaction value: -$328,920.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Options Exercise

Transaction value
Shares
+8,674
Change %
+7.4%
Price
Shares after
125,531
Date
27 Feb 2022
Ownership
Direct
Footnotes
F1, F2
BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value
$75,534
Shares
-3,102
Change %
-2.5%
Price
$24.35
Shares after
122,429
Date
27 Feb 2022
Ownership
Direct
Footnotes
F3
BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value
$19,821
Shares
-814
Change %
-0.66%
Price
$24.35
Shares after
121,615
Date
26 Feb 2022
Ownership
Direct
Footnotes
F4
BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value
$22,353
Shares
-918
Change %
-0.75%
Price
$24.35
Shares after
120,697
Date
27 Feb 2022
Ownership
Direct
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BHC transaction Derivative

Restricted Share Units

Award

Transaction value
Shares
+8,674
Change %
Price
Shares after
0
Date
27 Feb 2022
Ownership
Direct
Underlying class
Common Shares, No Par Value
Underlying amount
8,674
Exercise price
Footnotes
F1, F2
BHC transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
$211,212
Shares
-8,674
Change %
-100%
Price
$24.35
Shares after
0
Date
27 Feb 2022
Ownership
Direct
Underlying class
Common Shares, No Par Value
Underlying amount
0
Exercise price
$24.35
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer.

Footnote F2

Each PSU converts into Common Shares on a one-for-one basis

Footnote F3

This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs.

Footnote F4

This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").

Footnote F5

This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .